Epigenetic therapy shows promise against treatment-resistant AML: Study Written By Dr. Kamal Kant Kohli21 July 2026 8:30 PM ISTResearchers at The University of Texas MD-Anderson Cancer Center have discovered that an investigational epigenetic therapy remained effective in...
USFDA Approves First Wearable Cancer Drug Delivery System for Sanofi's Sarclisa Written By sheeba farhat13 July 2026 9:54 PM ISTLondon: The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering...
Sanofi's Wearable Sarclisa Receives USFDA Approval for Blood Cancer Treatment Written By sheeba farhat11 July 2026 6:26 PM ISTLondon: The U.S. Food and Drug Administration said on Friday it has approved a wearable form of Sanofi's blood cancer drug, Sarclisa, offering...
FDA approves Tregzi to Prevent Stem Cell Transplant Complications in Blood Cancer Patients Written By Dr. Kamal Kant Kohli3 July 2026 8:45 AM ISTThe U.S. Food and Drug Administration has approved Tregzi, the first regulatory T (Treg) cell-based immunotherapy for improving chronic...
Kolhapur Civil Hospital to launch Maharashtra's first bone marrow transplant unit Written By Medical Dialogues Bureau21 Jun 2026 11:00 AM ISTKolhapur: Chhatrapati Pramila Raje Civil Hospital in Kolhapur is preparing to introduce a bone marrow transplant facility, marking a major expansion...
Roche Strikes USD 2.3 Billion Nurix Deal for Blood Cancer Drug Bexobrutideg Written By sheeba farhat9 Jun 2026 8:03 PM ISTZurich: Swiss pharmaceutical giant Roche has entered an exclusive licensing and collaboration agreement with Nurix Therapeutics of up to USD 2.3...
USFDA Clears AbbVie's Pivekimab for Rare Blood Cancer Treatment Written By sheeba farhat29 May 2026 10:30 AM ISTBengaluru: The U.S. Food and Drug Administration (USFDA) on Wednesday approved AbbVie's drug to treat blastic plasmacytoid dendritic cell neoplasm...
FDA Warns of New Blood Cancer Risk With Tazemetostat Written By Medha Baranwal15 May 2026 8:00 PM ISTUSA: The FDA has alerted healthcare providers about an increased risk of developing new primary hematologic malignancies (blood cancers) in patients...
Simple blood tests may predict response to lymphoma treatment , suggests research Written By Dr. Kamal Kant Kohli9 April 2026 8:30 PM ISTMany people with an aggressive blood cancer called diffuse large B cell lymphoma are cured by the current gold standard of treatment: an antibody...
AI Potential in Transforming Management of Hematologic Malignancies- Latest Cureus Review Written By Dr Rohini Sharma13 Feb 2026 12:15 PM ISTA recent review concluded that artificial intelligence (AI) is rapidly transforming the diagnosis and treatment of haematological malignancies by ...
Case Management of Chemotherapy Induced Anemia (CIA) with Darbepoetin Alfa in a Patient with Metastatic Breast Carcinoma - Dr Adwaita Gore Written By Dr Adwaita Gore9 Feb 2026 10:45 AM ISTIn this video, Dr. Adwaita A. Gore, Medical Oncologist at S L Raheja Hospital, Mumbai, presents a real-world case highlighting the management of...
AbbVie Loses India Patent Bid for Cancer Drug Venetoclax, Generics Set to Enter Market Written By Parthika Patel23 Jan 2026 4:57 PM ISTNew Delhi: In a major development for cancer drug accessibility in India, the Indian Patent Office (IPO) has rejected a patent application filed by...
